Lunai Bioworks Inc. (LNAI) Stock
Healthcare · Biotechnology · US
$3.56
-11.00%
Last updated Jun 19, 2026 00:03 UTC
LNAI Key Statistics
Market Cap$63.36M
P/E (TTM)-0.47
P/S (TTM)—
P/B (TTM)-6.17
Revenue (TTM)$0.00
EPS (TTM)$-7.55
Dividend Yield—
ROE (TTM)-1,241.35%
Net Margin0.00%
Gross Margin0.00%
52W High$5.02
52W Low$0.15
Analyst View—
Price Target—
Employees29
Volume298,269
About Lunai Bioworks Inc.
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
CEO: David H. Weinstein. Company website
See LNAI live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open LNAI in Terminal See plans